Clock Drawing Test

The Clock Drawing Test (CDT) is a brief neuropsychological assessment task in which a person is asked to draw the face of a clock — either on a pre-drawn circle or on a blank page — and then mark the hands to indicate a specific time (commonly 10 minutes past 11, or 3:40). Despite its apparent simplicity, the task requires the coordinated deployment of multiple cognitive functions: visuospatial ability, executive planning and organization, working memory (to hold the clock format in mind while drawing), and semantic memory.

Clock drawing has been used clinically for over a century. The first standardized neuropsychological description of clock drawing in dementia was published by Critchley in 1953. Multiple scoring systems have been developed, ranging from simple 2-point normal/abnormal designations (as used in the Mini-Cog) to detailed 10-20 point scoring systems that quantify specific error types.

The most common errors in cognitively impaired individuals include: number omissions or repetitions, numbers placed outside the circle, spatial compression or expansion of number distribution, incorrect time marking despite correctly drawn numbers, and perseveration (continuing to add numbers or features beyond what is needed).

The clock drawing test is sensitive to a broad range of cognitive impairments because it engages multiple cognitive systems simultaneously. Visuospatial errors in clock drawing can reflect posterior cortical atrophy (a variant of Alzheimer's) or parietal lobe involvement. Executive errors in organizing the number placement reflect frontal-executive dysfunction. These different error patterns can help differentiate between dementia types.

Artificial intelligence applied to digitized clock drawings has dramatically expanded the test's clinical utility. AI analysis measures hundreds of features that human scorers cannot reliably quantify — pen pressure, stroke timing, the kinematic profile of each stroke, spatial relationships between elements — achieving substantially higher sensitivity for MCI than conventional human scoring.

The test's accessibility and brevity have made it an enduring component of neuropsychological batteries, cognitive screening tools (including the Mini-Cog and MoCA), and an increasingly powerful digital biomarker in research and clinical development.